Postmenopausal Women
Conditions
Brief summary
Dry eye disease (DED) is a growing public health concern affecting quality of life and visual function, with a significant socio-economic impact. It is more prevalent in the females and is being specifically in the menopausal and postmenopausal age group. Bioptron light therapy is efficient in the elimination of allergic reactions, signs and symptoms of dry eye improving capillary circulation, immunity stimulation, relieving pain and establishing balance of tissue electromagnetic field
Detailed description
Around 60 postmenopausal women will be randomly divided into two equal groups, they all complain from dry eye symptoms, ranging from mild/normal to moderate and severe. Group(A): will receive patient education program for four weeks. Group(B): will receive patient education program and bioptron light therapy for four weeks
Interventions
DEVICEbioptron light therapy
patients will receive patient education program and bioptron light therapy for four weeks
Sponsors
Cairo University
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)
Eligibility
Sex/Gender
FEMALE
Age
50 Years to 65 Years
Healthy volunteers
No
Inclusion criteria
* All participants are postmenopausal women. * Their age above 50 years old * All participants aren't on any systematic therapy.
Exclusion criteria
* • Injuries and previous surgical treatment of eyes * All patients with diagnosis of chronic blepharitis, meibominitis or any other eye infections * Participants with autoimmune diseases such as Sjögren's syndrome (SS), rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE) * Diabetic participants will be excluded. * Smokers will be excluded from the study. * The use of Hormone Replacement Therapy
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Dry Eye-Related Quality-Of-Life Score (DEQS) | Dry Eye-Related Quality-Of-Life Score will be measured at baseline, and it will be measured again after four weeks | The Dry Eye-Related Quality-Of-Life Score questionnaire is a 15-item instrument for assessing subjective dry eye symptoms and their effects on activities of daily living within the previous week. 1. extremely good 2. very good 3. good 4. bad 5. very bad 6. extremely bad |
| Tear Breakup Time (TBUT) | Tear Breakup Time will be measured at baseline, and it will be measured again after four weeks | Tear Breakup Time Is the time interval between a complete blink and the appearance of the first break, discontinuity or dry spot observed in the tear film. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Schirmer's test | Schirmer's test will be measured at baseline, and after four weeks | The Schirmer test score is determined by the length of the moistened area of the strips (using the scale packaged with the strips) and the duration of the measurement in minutes. A score of greater than 10 mm in 5 minutes is accepted as normal. A score of less than 5 mm in 5 minutes indicates a tear deficiency. |
Countries
Egypt
Contacts
Primary ContactSara Ahmed, lecturer
Backup ContactAmel Yousef, Professor
Outcome results
None listed